Beyond extended myectomy for hypertrophic cardiomyopathy: the resection-plication-release (RPR) repair.

Ann Thorac Surg

Division of Cardiothoracic Surgery, St. Luke's-Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, New York, New York 10025, USA.

Published: July 2005

Background: Extended myectomy for left ventricular outflow tract obstruction (LVOTO) due to hypertrophic cardiomyopathy (HCM) has good long-term results. In addition to the midseptal resection (R) for HCM, our group has introduced a novel variation in anterior leaflet plication (P) and release (R) of papillary muscle attachments. We sought to investigate the medium-term success of this three-step repair that addresses all aspects of complex HCM pathology.

Methods: Nineteen patients underwent resection-plication-release repair for complex HCM pathology. Transesophageal echocardiography was performed on all patients preoperatively and postoperatively to assess adequacy of resection, left ventricular outflow tract gradients, and mitral valve function. All patients underwent transthoracic outpatient echocardiography at a mean follow-up of 2.4 +/- 2.1 years (range, 0.5 to 6).

Results: The average age of the patients was 57 +/- 14 years. The preoperative peak LVOTO was 137 +/- 45 mm Hg. The average degree of mitral regurgitation was 3.1. The average length of stay was 7.5 +/- 3.3 days. There were no readmissions or deaths in the group. Initial postoperative transesophageal echocardiography demonstrated marked reduction in LVOTO to 10 +/- 17 mm Hg (p < 0.0001) and significant improvement in mitral regurgitation to 0.2 (p < 0.0001). In follow-up, the LVOT gradient remained low at 6 +/- 14 (p > 0.0001) and mitral regurgitation remained insignificant at 0.4 (p < 0.0001).

Conclusions: Anterior leaflet plication and papillary muscle release are logical adjuncts to septal resection in the treatment of the complicated pathophysiology of obstructive HCM. Durable long-term results can be achieved with an aggressive approach to mitral valve pathology in conjunction with extended myectomy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2005.01.064DOI Listing

Publication Analysis

Top Keywords

extended myectomy
12
mitral regurgitation
12
hypertrophic cardiomyopathy
8
left ventricular
8
ventricular outflow
8
outflow tract
8
anterior leaflet
8
leaflet plication
8
papillary muscle
8
complex hcm
8

Similar Publications

Unlabelled: The combination of hypertrophic cardiomyopathy with outflow tract obstruction, severe pre-capillary and post-capillary pulmonary hypertension, and severe primary mitral regurgitation is rare and presents distinct management challenges.

Background And Clinical Significance: Pulmonary hypertension is an independent predictor of all-cause mortality in patients with hypertrophic cardiomyopathy managed medically and often precludes patients from undergoing cardiopulmonary bypass due to increased surgical morbidity and mortality. In studies specifically evaluating surgical myectomy, however, survival is favorable in patients with moderate-to-severe pulmonary hypertension.

View Article and Find Full Text PDF
Article Synopsis
  • Septal myectomy is the main treatment for patients with hypertrophic obstructive cardiomyopathy (HOCM) who don't respond to medication, but it's often based on subjective judgments.* -
  • A new preoperative planning method using computational fluid dynamics (CFD) and shape optimization aims to improve objective assessment of how much heart muscle needs to be removed during surgery.* -
  • Testing this method on 3 HOCM patients showed significant improvements in blood flow after surgery, suggesting that this approach could enhance preoperative evaluations for future patients.*
View Article and Find Full Text PDF
Article Synopsis
  • Transmitral myectomy for hypertrophic obstructive cardiomyopathy can be performed through minimally invasive approaches, providing an alternative to traditional surgery methods.
  • A new technique involves a longitudinal incision in the midline of the anterior mitral leaflet, allowing for septal myectomy while maintaining easier surgical access.
  • This method simplifies the procedure by avoiding the need for detaching the anterior leaflet and eliminates the use of patch materials, which can compromise the durability of the leaflets.
View Article and Find Full Text PDF

Midventricular obstruction (MVO) is a rare form of hypertrophic cardiomyopathy (HCM). While surgical treatment for HCM is among the most technically challenging cardiac operations for acquired disease, surgery for MVO is rarely reported. A 38-year-old man was admitted to our hospital with a cough and dyspnea.

View Article and Find Full Text PDF

MYBPC3-c.772G>A mutation results in haploinsufficiency and altered myosin cycling kinetics in a patient induced stem cell derived cardiomyocyte model of hypertrophic cardiomyopathy.

J Mol Cell Cardiol

June 2024

Department of Bioengineering, University of Washington, Seattle, WA 98109, USA; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA; Center for Translational Muscle Research, University of Washington, Seattle, WA 98109, USA. Electronic address:

Approximately 40% of hypertrophic cardiomyopathy (HCM) mutations are linked to the sarcomere protein cardiac myosin binding protein-C (cMyBP-C). These mutations are either classified as missense mutations or truncation mutations. One mutation whose nature has been inconsistently reported in the literature is the MYBPC3-c.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!